Unilabs uses Mindpeak’s AI software in the clinical routine Skip to main content

Media Release

30 June 2022

Unilabs uses Mindpeak’s AI software in the clinical routine

Geneva, 30 June 2022: Unilabs, the leading diagnostic services provider, now brought Mindpeak’s AI solutions into the clinical routine to speed up breast cancer diagnosis and make it more accurate.

“At Unilabs, we know time is at the essence when dealing with breast cancer, that it’s why we have been partnering with Mindpeak since March to cut reporting time,” said Unilabs Chief Medical and Operations Officer Dr Christian Rebhan. “The IKWG-guideline for scoring Ki-67 in breast cancer requires much more manual work by pathologists, and Sweden was the first country to adopt it. Fortunately, the Mindpeak‘s AI solution we have in place decreases the time needed per case by 80% or more, which allows us to better position ourselves as a reference centre for sent-in samples.”

Diagnosing breast cancer involves the detection and quantification of immunohistochemically stained breast tumour cells. This critical task takes a lot of time, and with the IKWG-guideline for “global scoring” the time needed at least triples if done manually.

“We are very pleased that our state-of-the-art AI tools with deep workflow integration are now used in clinical routine at Unilabs,” said Felix Faber, CEO of Mindpeak.  “Mindpeak’s AI solution reduces the reporting time to just a fraction while at the same time following the new guideline.”

Initially started at Unilabs St Göran’s lab in Stockholm, and rolled out in other parts of Sweden, Mindpeak’s AI software will progressively be introduced to other countries where Unilabs is present.

Welcome to the Unilabs website

Continue to the main corporate website

Or: Select a Unilabs country website from the list below